Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL) Meeting Abstract


Authors: Sauter, C. S.; Riviere, I.; Bernal, Y.; Wang, X. Y.; Purdon, T.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; Park, J. H.; Sadelain, M.; Brentjens, R. J.
Abstract Title: Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL)
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901827
PROVIDER: wos
DOI: 10.1200/JCO.2015.33.15_suppl.8515
Notes: Meeting Abstract: 8515 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Craig Moskowitz
    388 Moskowitz
  2. Renier J Brentjens
    231 Brentjens
  3. Sergio Andres Giralt
    610 Giralt
  4. Kevin Joseph Curran
    73 Curran
  5. Jae Hong Park
    178 Park
  6. Craig Steven Sauter
    199 Sauter
  7. Matthew J Matasar
    149 Matasar
  8. Michel W J Sadelain
    486 Sadelain
  9. Isabelle C Riviere
    189 Riviere
  10. Xiuyan Wang
    84 Wang
  11. Yvette J Bernal
    29 Bernal
  12. Terence John Purdon
    48 Purdon
  13. Sarah Min Kyung Yoo
    12 Yoo